Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344:581–90.

Article  CAS  PubMed  Google Scholar 

Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, et al. Clinical Practice Guideline Revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2022;150:e2022058859.

Article  PubMed  Google Scholar 

Hansen TWR, Wong RJ, Stevenson DK. Molecular physiology and pathophysiology of bilirubin handling by the blood, liver, intestine, and brain in the newborn. Physiol Rev. 2020;100:1291–346.

Article  CAS  PubMed  Google Scholar 

Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA. 1968;61:748–55.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Wong RJ, Bhutani VK, Stevenson DK. The importance of hemolysis and Its clinical detection in neonates with hyperbilirubinemia. Curr Pediatr Rev. 2017;13:193–8.

Article  CAS  PubMed  Google Scholar 

Lamola AA, Bhutani VK, Du L, Castillo Cuadrado M, Chen L, Shen Z, et al. Neonatal bilirubin binding capacity discerns risk of neurological dysfunction. Pediatr Res. 2015;77:334–9.

Article  CAS  PubMed  Google Scholar 

Bhutani VK, Wong RJ. Bilirubin neurotoxicity in preterm infants: risk and prevention. J Clin Neonatol. 2013;2:61–9.

Article  PubMed  PubMed Central  Google Scholar 

Bhutani VK, Wong R. Bilirubin-induced neurologic dysfunction (BIND). Semin Fetal Neonatal Med. 2015;20:1.

Article  PubMed  Google Scholar 

Tidmarsh GF, Wong RJ, Stevenson DK. End-tidal carbon monoxide and hemolysis. J Perinatol. 2014;34:577–81.

Article  CAS  PubMed  Google Scholar 

Bhutani VK, Srinivas S, Castillo Cuadrado ME, Aby JL, Wong RJ, Stevenson DK. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia. Acta Paediatr. 2016;105:e189–e94.

Article  CAS  PubMed  Google Scholar 

Christensen RD, Bahr TM, Wong RJ, Vreman HJ, Bhutani VK, Stevenson DK. A “Gold Standard” test for diagnosing and quantifying hemolysis in neonates and infants. J Perinatol. 2023;43:1541–7.

Article  PubMed  Google Scholar 

Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108:31–9.

Article  CAS  PubMed  Google Scholar 

Bhutani VK, Maisels MJ, Schutzman DL, Castillo Cuadrado ME, Aby JL, Bogen DL, et al. Identification of risk for neonatal haemolysis. Acta Paediatr. 2018;107:1350–6.

Article  CAS  PubMed  Google Scholar 

Valaes T. Problems with prediction of neonatal hyperbilirubinemia. Pediatrics. 2001;108:175–7.

Article  CAS  PubMed  Google Scholar 

Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics. 2003;111:886–93.

Article  PubMed  Google Scholar 

Watchko JF, Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med. 2010;15:169–75.

Article  PubMed  Google Scholar 

Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharm Toxicol. 1997;37:517–54.

Article  CAS  Google Scholar 

Kaplan M, Wong RJ, Stevenson DK. Hemolysis and glucose-6-phosphate dehydrogenase deficiency-related neonatal hyperbilirubinemia. Neonatology. 2018;114:223–5.

Article  CAS  PubMed  Google Scholar 

Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N. Engl J Med. 2008;359:1885–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arnold C, Tyson JE, Pedroza C, Carlo WA, Stevenson DK, Wong RJ, et al. Cycled phototherapy dose-finding study for extremely low-birth-weight infants: a randomized clinical trial. JAMA Pediatr. 2020;174:649–56.

Article  PubMed  Google Scholar 

Maines MD. Zinc•protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta. 1981;673:339–50.

Article  CAS  PubMed  Google Scholar 

Stevenson DK, Rodgers PA, Vreman HJ. The use of metalloporphyrins for the chemoprevention of neonatal jaundice. Am J Dis Child. 1989;143:353–6.

CAS  PubMed  Google Scholar 

Vreman HJ, Wong RJ, Stevenson DK. Alternative metalloporphyrins for the treatment of neonatal jaundice. J Perinatol. 2001;21:S108–13.

Article  PubMed  Google Scholar 

Schulz S, Wong RJ, Vreman HJ, Stevenson DK. Metalloporphyrins – an update. Front Pharm. 2012;3:68.

Article  Google Scholar 

Kappas A, Drummond GS, Manola T, Petmezaki S, Valaes T. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics. 1988;81:485–97.

CAS  PubMed  Google Scholar 

Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin. Pediatrics. 1998;101:E1.

Article  CAS  PubMed  Google Scholar 

Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics. 1994;93:1–11.

Article  CAS  PubMed  Google Scholar 

Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;103:1–5.

Article  CAS  PubMed  Google Scholar 

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. J Perinatol. 2016;36:533–9.

Article  CAS  PubMed  Google Scholar 

Rosenfeld WN, Hudak ML, Ruiz N, Gautam S, Jasmine Study Group. Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease. J Perinatol. 2022;42:110–5.

Article  CAS  PubMed  Google Scholar 

Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004;113:119–23.

Article  PubMed  Google Scholar 

Alexander D. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004;113:135.

Article  PubMed  Google Scholar 

Fujioka K, Kalish F, Wong RJ, Stevenson DK. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model. Pediatr Res. 2016;79:251–7.

Article  CAS  PubMed  Google Scholar 

Wong RJ, Schulz S, Espadas C, Vreman HJ, Rajadas J, Stevenson DK. Effects of light on metalloporphyrin-treated newborn mice. Acta Paediatr. 2014;103:474–9.

Article  CAS  PubMed  Google Scholar 

Poudel P, Adhikari S. Efficacy and safety concerns with Sn-mesoporphyrin as an adjunct therapy in neonatal hyperbilirubinemia: a literature review. Int J Pediatr. 2022;2022:2549161.

Article  PubMed  PubMed Central  Google Scholar 

Rodgers PA, Seidman DS, Wei PL, Dennery PA, Stevenson DK. Duration of action and tissue distribution of zinc protoporphyrin in neonatal rats. Pediatr Res. 1996;39:1041–9.

Article  CAS  PubMed  Google Scholar 

Vreman HJ, Rodgers PA, Stevenson DK. Zinc protoporphyrin administration for suppression of increased bilirubin production by iatrogenic hemolysis in rhesus neonates. J Pediatr. 1990;117:292–7.

Article  CAS  PubMed  Google Scholar 

Rodgers PA, Vreman HJ, Stevenson DK. Heme catabolism in rhesus neonates inhibited by zinc protoporphyrin. Dev Pharm Ther. 1990;14:216–22.

Article  CAS  Google Scholar 

Labbe RF, Vreman HJ, Stevenson DK. Zinc protoporphyrin: a metabolite with a mission. Clin Chem. 1999;45:2060–72.

Article  CAS  PubMed